•Psoriasis (PsO) is an immune mediated chronic inflammatory disease with severe disease burden associated with several comorbidities and impact on quality of life. •The Corrona PsO registry, in collaboration with the National Psoriasis Foundation (NPF), was launched in April 2015 targeting to recruit approximately 200 sites with ~10,000 patients and an expected follow-up of at least 8 years and to study the comparative effectiveness, safety and treatment patterns of approved systemic therapies in a real world setting.
Characterization of Disease Burden, Comorbidities and Therapy Use of Patients with Psoriasis at Enrollment: Results from the Corrona Psoriasis Registry
Association between disease severity and body mass index in psoriasis patients enrolled in the Corrona Psoriasis Registry
•Recent studies have shown strong association between obesity and psoriasis (PsO) disease activity that may lead to implications in disease management. •The objective of this study is to examine the association between body mass index (BMI) (an index for adiposity) and PsO disease severity in an observational cohort of PsO patients.